Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in Invasive Cardiology

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stéphane Cook, Prof, University of Freiburg
ClinicalTrials.gov Identifier:
NCT01612117
First received: May 30, 2012
Last updated: May 27, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Publications: